These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38780041)

  • 1. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
    Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
    Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma.
    Shi JY; Duan M; Sun QM; Yang L; Wang ZC; Mynbaev OA; He YF; Wang LY; Zhou J; Tang QQ; Cao Y; Fan J; Wang XY; Gao Q
    Tumour Biol; 2016 Jul; 37(7):9909-17. PubMed ID: 26813566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
    Huang H; Lan C; Wei Y; Nong J; Liao X; Ye X; Deng G; Peng T; Zhou X
    Aging (Albany NY); 2024 Mar; 16(7):6229-6261. PubMed ID: 38552222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Transcriptome Analysis Reveals Interaction between CCL19+ Inflammatory Keratinocytes and CCR7+ Dendritic Cells and B Cells in Pemphigus.
    Wang Y; Zhao S; Zhang X; Xia D; Xiao Y; Zhou X; Zhan T; Xia X; Shu Y; Xu H; Li W
    J Invest Dermatol; 2024 Oct; 144(10):2301-2305.e8. PubMed ID: 38537931
    [No Abstract]   [Full Text] [Related]  

  • 7. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.
    Shi JY; Yang LX; Wang ZC; Wang LY; Zhou J; Wang XY; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Tang QQ; Gao Q; Fan J
    J Pathol; 2015 Mar; 235(4):546-58. PubMed ID: 25255875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.
    Zhang Q; He Y; Luo N; Patel SJ; Han Y; Gao R; Modak M; Carotta S; Haslinger C; Kind D; Peet GW; Zhong G; Lu S; Zhu W; Mao Y; Xiao M; Bergmann M; Hu X; Kerkar SP; Vogt AB; Pflanz S; Liu K; Peng J; Ren X; Zhang Z
    Cell; 2019 Oct; 179(4):829-845.e20. PubMed ID: 31675496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.
    Guo DZ; Zhang X; Zhang SQ; Zhang SY; Zhang XY; Yan JY; Dong SY; Zhu K; Yang XR; Fan J; Zhou J; Huang A
    Mol Cancer; 2024 Aug; 23(1):157. PubMed ID: 39095854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD74 facilitates immunotherapy response by shaping the tumor microenvironment of hepatocellular carcinoma.
    Cheng J; Li J; Jiang X; Ma X; Li B; Zhai H; Luo X; Zhou Y; Wu J; Zhang Z; Chen S; Wang Y
    Mol Med; 2024 Aug; 30(1):116. PubMed ID: 39118044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
    Liu T; Wu H; Qi J; Qin C; Zhu Q
    Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma.
    Zhang Q; Qiao L; Liao J; Liu Q; Liu P; Liu L
    J Cell Mol Med; 2021 Apr; 25(8):3772-3784. PubMed ID: 33616276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis
    Qiu LW; Liu YF; Cao XQ; Wang Y; Cui XH; Ye X; Huang SW; Xie HJ; Zhang HJ
    World J Gastroenterol; 2020 May; 26(18):2126-2137. PubMed ID: 32476780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.